ReP USP - Resultado da busca

Artigo de periodico
Adenovirus 36 seropositivity is related to the expression of anti-adipogenic lncRNAs GAS5 and MEG3 in adipose tissue obtained from subjects with obesity (2024)
Manriquez, Victor; Brito, Roberto; Pavez, Monica; Sapunar, Jorge; Fonseca, Luis; Molina, Víctor; Ortiz, Eugenia; Baeza, Romilio; Reimer, Camila; Charles, Maria; Schneider, Constance; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Cerda, Alvaro
Source: international journal of obesity. Unidade: FCF
Subjects: ADENOVÍRUS, OBESIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANRIQUEZ, Victor et al. Adenovirus 36 seropositivity is related to the expression of anti-adipogenic lncRNAs GAS5 and MEG3 in adipose tissue obtained from subjects with obesity. international journal of obesity, 2024Tradução . . Disponível em: https://dx.doi.org/10.1038/s41366-024-01555-x. Acesso em: 06 jul. 2024.
APA
Manriquez, V., Brito, R., Pavez, M., Sapunar, J., Fonseca, L., Molina, V., et al. (2024). Adenovirus 36 seropositivity is related to the expression of anti-adipogenic lncRNAs GAS5 and MEG3 in adipose tissue obtained from subjects with obesity. international journal of obesity. doi:10.1038/s41366-024-01555-x
NLM
Manriquez V, Brito R, Pavez M, Sapunar J, Fonseca L, Molina V, Ortiz E, Baeza R, Reimer C, Charles M, Schneider C, Hirata MH, Hirata RDC, Cerda A. Adenovirus 36 seropositivity is related to the expression of anti-adipogenic lncRNAs GAS5 and MEG3 in adipose tissue obtained from subjects with obesity [Internet]. international journal of obesity. 2024 ;[citado 2024 jul. 06 ] Available from: https://dx.doi.org/10.1038/s41366-024-01555-x
Vancouver
Manriquez V, Brito R, Pavez M, Sapunar J, Fonseca L, Molina V, Ortiz E, Baeza R, Reimer C, Charles M, Schneider C, Hirata MH, Hirata RDC, Cerda A. Adenovirus 36 seropositivity is related to the expression of anti-adipogenic lncRNAs GAS5 and MEG3 in adipose tissue obtained from subjects with obesity [Internet]. international journal of obesity. 2024 ;[citado 2024 jul. 06 ] Available from: https://dx.doi.org/10.1038/s41366-024-01555-x
Artigo de periodico
Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study (2023)
Fajardo, Cristina Moreno ; Cerda, Alvaro ; Bortolin, Raul Hernandes ; Oliveira, Raquel de; Stefani, Tamires Invencioni Moraes; Santos, Marina Aparecida dos; Braga, Aécio Assunção; Dorea, Egídio Lima; Bernik, Marcia Martins Silveira; Bastos, Gisele Medeiros; Sampaio, Marcelo Ferraz; Damasceno, Nágila Raquel Teixeira; Verlengia, Rozangela; Oliveira, Maria Rita Marques de; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Nutrition Research. Unidades: FCF, HU, FSP
Subjects: POLIMORFISMO, OBESIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAJARDO, Cristina Moreno et al. Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study. Nutrition Research, v. 119, p. 21-32, 2023Tradução . . Disponível em: https://dx.doi.org/10.1016/j.nutres.2023.08.008. Acesso em: 06 jul. 2024.
APA
Fajardo, C. M., Cerda, A., Bortolin, R. H., Oliveira, R. de, Stefani, T. I. M., Santos, M. A. dos, et al. (2023). Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study. Nutrition Research, 119, 21-32. doi:10.1016/j.nutres.2023.08.008
NLM
Fajardo CM, Cerda A, Bortolin RH, Oliveira R de, Stefani TIM, Santos MA dos, Braga AA, Dorea EL, Bernik MMS, Bastos GM, Sampaio MF, Damasceno NRT, Verlengia R, Oliveira MRM de, Hirata MH, Hirata RDC. Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study [Internet]. Nutrition Research. 2023 ; 119 21-32.[citado 2024 jul. 06 ] Available from: https://dx.doi.org/10.1016/j.nutres.2023.08.008
Vancouver
Fajardo CM, Cerda A, Bortolin RH, Oliveira R de, Stefani TIM, Santos MA dos, Braga AA, Dorea EL, Bernik MMS, Bastos GM, Sampaio MF, Damasceno NRT, Verlengia R, Oliveira MRM de, Hirata MH, Hirata RDC. Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study [Internet]. Nutrition Research. 2023 ; 119 21-32.[citado 2024 jul. 06 ] Available from: https://dx.doi.org/10.1016/j.nutres.2023.08.008
Artigo de periodico
Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia (2023)
Cerda, Alvaro; Bortolin, Raul Hernandes ; Yoshinaga, Marcos Yukio ; Freitas, Renata Caroline Costa de ; Hernandez, Carolina Dagli; Borges, Jessica Bassani; Oliveira, Victor Fernandes de ; Gonçalves, Rodrigo Marques; Faludi, André Arpad; Bastos, Gisele Medeiros ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Chemistry and Physics of Lipids. Unidades: FCF, ICB
Subjects: BIOMARCADORES, ESTATINAS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia. Chemistry and Physics of Lipids, v. 257, p. 1-9 art. 105348, 2023Tradução . . Disponível em: https://dx.doi.org/10.1016/j.chemphyslip.2023.105348. Acesso em: 06 jul. 2024.
APA
Cerda, A., Bortolin, R. H., Yoshinaga, M. Y., Freitas, R. C. C. de, Hernandez, C. D., Borges, J. B., et al. (2023). Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia. Chemistry and Physics of Lipids, 257, 1-9 art. 105348. doi:10.1016/j.chemphyslip.2023.105348
NLM
Cerda A, Bortolin RH, Yoshinaga MY, Freitas RCC de, Hernandez CD, Borges JB, Oliveira VF de, Gonçalves RM, Faludi AA, Bastos GM, Hirata RDC, Hirata MH. Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia [Internet]. Chemistry and Physics of Lipids. 2023 ; 257 1-9 art. 105348.[citado 2024 jul. 06 ] Available from: https://dx.doi.org/10.1016/j.chemphyslip.2023.105348
Vancouver
Cerda A, Bortolin RH, Yoshinaga MY, Freitas RCC de, Hernandez CD, Borges JB, Oliveira VF de, Gonçalves RM, Faludi AA, Bastos GM, Hirata RDC, Hirata MH. Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia [Internet]. Chemistry and Physics of Lipids. 2023 ; 257 1-9 art. 105348.[citado 2024 jul. 06 ] Available from: https://dx.doi.org/10.1016/j.chemphyslip.2023.105348
Artigo de periodico
Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes (2022)
Hirata, Rosario Dominguez Crespo ; Genvigir, Fabiana Dalla Vecchia ; Hirata, Thiago Dominguez Crespo ; Cerda, Alvaro ; Hirata, Mario Hiroyuki
Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: TRANSPLANTE DE RIM, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Rosario Dominguez Crespo et al. Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes. Brazilian Journal of Pharmaceutical Sciences, v. 58, p. 1-22 art. e201188, 2022Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902022e201188. Acesso em: 06 jul. 2024.
APA
Hirata, R. D. C., Genvigir, F. D. V., Hirata, T. D. C., Cerda, A., & Hirata, M. H. (2022). Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes. Brazilian Journal of Pharmaceutical Sciences, 58, 1-22 art. e201188. doi:10.1590/s2175-97902022e201188
NLM
Hirata RDC, Genvigir FDV, Hirata TDC, Cerda A, Hirata MH. Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2022 ; 58 1-22 art. e201188.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1590/s2175-97902022e201188
Vancouver
Hirata RDC, Genvigir FDV, Hirata TDC, Cerda A, Hirata MH. Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2022 ; 58 1-22 art. e201188.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1590/s2175-97902022e201188
Artigo de periodico
Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia (2022)
Hernandez, Carolina Dagli ; Borges, Jéssica Bassani ; Marçal, Elisangela da Silva Rodrigues; Freitas, Renata Caroline Costa de ; Mori, Augusto Akira ; Gonçalves, Rodrigo Marques; Faludi, André Arpad ; Oliveira, Victor Fernandes de ; Ferreira, Glaucio Monteiro ; Bastos, Gisele Medeiros ; Zhou, Yitian ; Lauschke, Volker Martin ; Cerda, Alvaro ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmaceutics. Unidade: FCF
Subjects: HIPERCOLESTEROLEMIA, ESTATINAS, VARIAÇÃO GENÉTICA, FARMACOGENÉTICA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia. Pharmaceutics, v. 14, p. 1-20 art. 944, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14050944. Acesso em: 06 jul. 2024.
APA
Hernandez, C. D., Borges, J. B., Marçal, E. da S. R., Freitas, R. C. C. de, Mori, A. A., Gonçalves, R. M., et al. (2022). Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia. Pharmaceutics, 14, 1-20 art. 944. doi:10.3390/pharmaceutics14050944
NLM
Hernandez CD, Borges JB, Marçal E da SR, Freitas RCC de, Mori AA, Gonçalves RM, Faludi AA, Oliveira VF de, Ferreira GM, Bastos GM, Zhou Y, Lauschke VM, Cerda A, Hirata MH, Hirata RDC. Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia [Internet]. Pharmaceutics. 2022 ; 14 1-20 art. 944.[citado 2024 jul. 06 ] Available from: https://doi.org/10.3390/pharmaceutics14050944
Vancouver
Hernandez CD, Borges JB, Marçal E da SR, Freitas RCC de, Mori AA, Gonçalves RM, Faludi AA, Oliveira VF de, Ferreira GM, Bastos GM, Zhou Y, Lauschke VM, Cerda A, Hirata MH, Hirata RDC. Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia [Internet]. Pharmaceutics. 2022 ; 14 1-20 art. 944.[citado 2024 jul. 06 ] Available from: https://doi.org/10.3390/pharmaceutics14050944
Artigo de periodico
Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients (2021)
Cerda, Alvaro ; Amaral, Adonai Aralim; Oliveira, Raquel de; Moraes, Tamiris Invencioni; Braga, Aécio Assunção; Saldarriaga, Magda Elizabeth Graciano; Fajardo, Cristina Moreno ; Hirata, Thiago Dominguez Crespo ; Bonezi, Vivian; Salazar, Antony Brayan Campos ; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: International of Journal Molecular Sciences. Unidades: FCF, HU
Subjects: OBESIDADE, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients. International of Journal Molecular Sciences, v. 22, p. 1-14 art. 1468, 2021Tradução . . Disponível em: https://doi.org/10.3390/ijms22031468. Acesso em: 06 jul. 2024.
APA
Cerda, A., Amaral, A. A., Oliveira, R. de, Moraes, T. I., Braga, A. A., Saldarriaga, M. E. G., et al. (2021). Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients. International of Journal Molecular Sciences, 22, 1-14 art. 1468. doi:10.3390/ijms22031468
NLM
Cerda A, Amaral AA, Oliveira R de, Moraes TI, Braga AA, Saldarriaga MEG, Fajardo CM, Hirata TDC, Bonezi V, Salazar ABC, Dórea EL, Bernik MMS, Hirata MH, Hirata RDC. Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients [Internet]. International of Journal Molecular Sciences. 2021 ; 22 1-14 art. 1468.[citado 2024 jul. 06 ] Available from: https://doi.org/10.3390/ijms22031468
Vancouver
Cerda A, Amaral AA, Oliveira R de, Moraes TI, Braga AA, Saldarriaga MEG, Fajardo CM, Hirata TDC, Bonezi V, Salazar ABC, Dórea EL, Bernik MMS, Hirata MH, Hirata RDC. Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients [Internet]. International of Journal Molecular Sciences. 2021 ; 22 1-14 art. 1468.[citado 2024 jul. 06 ] Available from: https://doi.org/10.3390/ijms22031468
Artigo de periodico
Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells (2021)
Cerda, Alvaro ; Bortolin, Raul Hernandes ; Manriquez, Victor; Salazar, Luis A ; Zambrano, Tomás ; Fajardo, Cristina Moreno ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacological Reports. Unidade: FCF
Subjects: MICRORNAS, LIPÍDEOS, MICRORNAS, EXPRESSÃO GÊNICA, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells. Pharmacological Reports, v. 73, p. 1-13 art. 868–880, 2021Tradução . . Disponível em: https://doi.org/10.1007/s43440-021-00241-3. Acesso em: 06 jul. 2024.
APA
Cerda, A., Bortolin, R. H., Manriquez, V., Salazar, L. A., Zambrano, T., Fajardo, C. M., et al. (2021). Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells. Pharmacological Reports, 73, 1-13 art. 868–880. doi:10.1007/s43440-021-00241-3
NLM
Cerda A, Bortolin RH, Manriquez V, Salazar LA, Zambrano T, Fajardo CM, Hirata MH, Hirata RDC. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells [Internet]. Pharmacological Reports. 2021 ; 73 1-13 art. 868–880.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1007/s43440-021-00241-3
Vancouver
Cerda A, Bortolin RH, Manriquez V, Salazar LA, Zambrano T, Fajardo CM, Hirata MH, Hirata RDC. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells [Internet]. Pharmacological Reports. 2021 ; 73 1-13 art. 868–880.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1007/s43440-021-00241-3
Artigo de periodico
Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol (2021)
Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Ferreira, Glaucio Monteiro ; Los, Bruna; Barbosa, Thais Kristini Almendros Afonso; Marçal, Elisangela da Silva Rodrigues; Hernandez, Carolina Dagli; Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Mori, Augusto Akira ; Hirata, Thiago Dominguez Crespo ; Nakaya, Helder Takashi Imoto ; Bastos, Gisele Medeiros ; Thurow, Helena Strelow ; Gonçalves, Rodrigo Marques; Araújo, Daniel Branco de; Zatz, Henry Paulo; Bertolami, Adriana; Faludi, André Arpad; Bertolami, Marcelo Chiara ; Sousa, Amanda Guerra de Moraes Rego ; França, Joao Italo Dias ; Jannes, Cinthia Elim; Pereira, Alexandre da Costa; Nakazone, Marcelo Arruda; Souza, Dorotéia Rossi Silva; Carmo, Tayanne Silva; Sampaio, Marcelo Ferraz; Gorjão, Renata ; Curi, Tania Cristina Pithon ; Moriel, Patricia; Silbiger, Vivian Nogueira ; Luchessi, André Ducati ; Araújo, Jéssica Nayara Góes de; Naslavsky, Michel ; Wang, Jaqueline Yu Ting; Kronenberger, Thales ; Cerda, Alvaro ; Wang, Hui Tzu Lin; Garofalo, Adriana Regina; Fajardo, Cristina Moreno ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Research in Social and Administrative Pharmacy. Unidades: FCF, IDPC, FM, IB
Subjects: GENÔMICA, HIPERCOLESTEROLEMIA, FARMACOGENÉTICA, EXONS, LINFÓCITOS, LINHAGEM CELULAR, MUTAGÊNESE, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Jéssica Bassani et al. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, v. 17, n. 7, p. 1347-1355, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.sapharm.2020.10.007. Acesso em: 06 jul. 2024.
APA
Borges, J. B., Oliveira, V. F. de, Ferreira, G. M., Los, B., Barbosa, T. K. A. A., Marçal, E. da S. R., et al. (2021). Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, 17( 7), 1347-1355. doi:10.1016/j.sapharm.2020.10.007
NLM
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Vancouver
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Artigo de periodico
High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome (2021)
Braga, Aécio Assunção ; Bortolin, Raul Hernandes ; Saldarriaga, Magda Elizabeth Graciano ; Hirata, Thiago Dominguez Crespo ; Cerda, Alvaro; Freitas, Renata Caroline Costa de ; Wang, Hui Tzu Lin ; Borges, Jessica B; França, Joao Italo Dias ; Masi, Laureane Nunes ; Curi, Rui ; Curi, Tania Cristina Phiton ; Sampaio, Marcelo Ferraz; Castro, Lara R; Bastos, Gisele Medeiros ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Epigenomics. Unidade: FCF
Subjects: ADIPOSIDADE, SÍNDROME X METABÓLICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGA, Aécio Assunção et al. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome. Epigenomics, v. 13, n. 6 p. 423–436, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0247. Acesso em: 06 jul. 2024.
APA
Braga, A. A., Bortolin, R. H., Saldarriaga, M. E. G., Hirata, T. D. C., Cerda, A., Freitas, R. C. C. de, et al. (2021). High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome. Epigenomics, 13( 6 p. 423–436). doi:10.2217/epi-2020-0247
NLM
Braga AA, Bortolin RH, Saldarriaga MEG, Hirata TDC, Cerda A, Freitas RCC de, Wang HTL, Borges JB, França JID, Masi LN, Curi R, Curi TCP, Sampaio MF, Castro LR, Bastos GM, Hirata RDC, Hirata MH. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome [Internet]. Epigenomics. 2021 ; 13( 6 p. 423–436):[citado 2024 jul. 06 ] Available from: https://doi.org/10.2217/epi-2020-0247
Vancouver
Braga AA, Bortolin RH, Saldarriaga MEG, Hirata TDC, Cerda A, Freitas RCC de, Wang HTL, Borges JB, França JID, Masi LN, Curi R, Curi TCP, Sampaio MF, Castro LR, Bastos GM, Hirata RDC, Hirata MH. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome [Internet]. Epigenomics. 2021 ; 13( 6 p. 423–436):[citado 2024 jul. 06 ] Available from: https://doi.org/10.2217/epi-2020-0247
Artigo de periodico
Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study (2020)
Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Genvigir, Fabiana Dalla Vecchia ; Bonezi, Vivian; Hirata, Thiago Dominguez Crespo ; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Cerda, Alvaro ; Doi, Sonia Quateli; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Epigenomics. Unidade: FCF
Subjects: TRANSPLANTE DE RIM, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Renata Caroline Costa de et al. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study. Epigenomics, v. 12, n. 22, p. 2019-2034, 2020Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0160. Acesso em: 06 jul. 2024.
APA
Freitas, R. C. C. de, Bortolin, R. H., Genvigir, F. D. V., Bonezi, V., Hirata, T. D. C., Felipe, C. R., et al. (2020). Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study. Epigenomics, 12( 22), 2019-2034. doi:10.2217/epi-2020-0160
NLM
Freitas RCC de, Bortolin RH, Genvigir FDV, Bonezi V, Hirata TDC, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Doi SQ, Hirata MH, Hirata RDC. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study [Internet]. Epigenomics. 2020 ; 12( 22): 2019-2034.[citado 2024 jul. 06 ] Available from: https://doi.org/10.2217/epi-2020-0160
Vancouver
Freitas RCC de, Bortolin RH, Genvigir FDV, Bonezi V, Hirata TDC, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Doi SQ, Hirata MH, Hirata RDC. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study [Internet]. Epigenomics. 2020 ; 12( 22): 2019-2034.[citado 2024 jul. 06 ] Available from: https://doi.org/10.2217/epi-2020-0160
Artigo de periodico
CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy (2020)
Genvigir, Fabiana Dalla Vecchia; Campos-Salazar, Antony Brayan ; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Doi, Sonia de Quateli; Cerda, Alvaro; Hirata, Mario Hiroyuki ; Herrero, María José; Hirata, Rosario Dominguez Crespo
Source: Pharmacogenomics. Unidade: FCF
Subjects: TRANSPLANTE DE RIM, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy. Pharmacogenomics, v. 21, n. 1, p. 7-21, 2020Tradução . . Disponível em: https://doi.org/10.2217/pgs-2019-0120. Acesso em: 06 jul. 2024.
APA
Genvigir, F. D. V., Campos-Salazar, A. B., Felipe, C. R., Silva Junior, H. T., Pestana, J. O. M., Doi, S. de Q., et al. (2020). CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy. Pharmacogenomics, 21( 1), 7-21. doi:10.2217/pgs-2019-0120
NLM
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Pestana JOM, Doi S de Q, Cerda A, Hirata MH, Herrero MJ, Hirata RDC. CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy [Internet]. Pharmacogenomics. 2020 ; 21( 1): 7-21.[citado 2024 jul. 06 ] Available from: https://doi.org/10.2217/pgs-2019-0120
Vancouver
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Pestana JOM, Doi S de Q, Cerda A, Hirata MH, Herrero MJ, Hirata RDC. CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy [Internet]. Pharmacogenomics. 2020 ; 21( 1): 7-21.[citado 2024 jul. 06 ] Available from: https://doi.org/10.2217/pgs-2019-0120
Artigo de periodico
Mycophenolic acid pharmacogenomics in kidney transplantation (2020)
Genvigir, Fabiana Dalla Vecchia; Cerda, Alvaro ; Hirata, Thiago Dominguez Crespo ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Journal of Translational Genetics and Genomics. Unidade: FCF
Subjects: TRANSPLANTE DE RIM, FÁRMACOS IMUNOSSUPRESSORES, FARMACODINÂMICA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. Mycophenolic acid pharmacogenomics in kidney transplantation. Journal of Translational Genetics and Genomics, v. 4, p. 320-55, 2020Tradução . . Disponível em: https://doi.org/10.20517/jtgg.2020.37. Acesso em: 06 jul. 2024.
APA
Genvigir, F. D. V., Cerda, A., Hirata, T. D. C., Hirata, M. H., & Hirata, R. D. C. (2020). Mycophenolic acid pharmacogenomics in kidney transplantation. Journal of Translational Genetics and Genomics, 4, 320-55. doi:10.20517/jtgg.2020.37
NLM
Genvigir FDV, Cerda A, Hirata TDC, Hirata MH, Hirata RDC. Mycophenolic acid pharmacogenomics in kidney transplantation [Internet]. Journal of Translational Genetics and Genomics. 2020 ; 4 320-55.[citado 2024 jul. 06 ] Available from: https://doi.org/10.20517/jtgg.2020.37
Vancouver
Genvigir FDV, Cerda A, Hirata TDC, Hirata MH, Hirata RDC. Mycophenolic acid pharmacogenomics in kidney transplantation [Internet]. Journal of Translational Genetics and Genomics. 2020 ; 4 320-55.[citado 2024 jul. 06 ] Available from: https://doi.org/10.20517/jtgg.2020.37
Artigo de periodico
Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy (2020)
Bonezi, Vivian; Genvigir, Fabiana Dalla Vecchia; Salgado, Patricia de Cássia; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Cerda, Alvaro ; Doi, Sonia Quateli; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Annals of Translational Medicine. Unidade: FCF
Subjects: EXPRESSÃO GÊNICA, TRANSPLANTE DE RIM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONEZI, Vivian et al. Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy. Annals of Translational Medicine, v. 8, n. 17 p. 1-14 art. 1051, 2020Tradução . . Disponível em: https://doi.org/10.21037/atm-20-1757. Acesso em: 06 jul. 2024.
APA
Bonezi, V., Genvigir, F. D. V., Salgado, P. de C., Felipe, C. R., Silva Junior, H. T., Pestana, J. O. M., et al. (2020). Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy. Annals of Translational Medicine, 8( 17 p. 1-14 art. 1051). doi:10.21037/atm-20-1757
NLM
Bonezi V, Genvigir FDV, Salgado P de C, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Doi SQ, Hirata MH, Hirata RDC. Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy [Internet]. Annals of Translational Medicine. 2020 ; 8( 17 p. 1-14 art. 1051):[citado 2024 jul. 06 ] Available from: https://doi.org/10.21037/atm-20-1757
Vancouver
Bonezi V, Genvigir FDV, Salgado P de C, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Doi SQ, Hirata MH, Hirata RDC. Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy [Internet]. Annals of Translational Medicine. 2020 ; 8( 17 p. 1-14 art. 1051):[citado 2024 jul. 06 ] Available from: https://doi.org/10.21037/atm-20-1757
Artigo de periodico
Characterization of the adipogenic protein E4orf1 from adenovirus 36 through an in silico approach (2020)
Gutiérrez, Alvaro; Ferreira, Glaucio Monteiro ; Machuca, Juan; Venthur, Herbert; Feres, Fausto; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Cerda, Alvaro
Source: Journal of Molecular Modeling. Unidade: FCF
Subjects: ADENOVÍRUS, OBESIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUTIÉRREZ, Alvaro et al. Characterization of the adipogenic protein E4orf1 from adenovirus 36 through an in silico approach. Journal of Molecular Modeling, v. 26, p. 1-9 art. 285, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00894-020-04531-0. Acesso em: 06 jul. 2024.
APA
Gutiérrez, A., Ferreira, G. M., Machuca, J., Venthur, H., Feres, F., Hirata, M. H., et al. (2020). Characterization of the adipogenic protein E4orf1 from adenovirus 36 through an in silico approach. Journal of Molecular Modeling, 26, 1-9 art. 285. doi:10.1007/s00894-020-04531-0
NLM
Gutiérrez A, Ferreira GM, Machuca J, Venthur H, Feres F, Hirata MH, Hirata RDC, Cerda A. Characterization of the adipogenic protein E4orf1 from adenovirus 36 through an in silico approach [Internet]. Journal of Molecular Modeling. 2020 ; 26 1-9 art. 285.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1007/s00894-020-04531-0
Vancouver
Gutiérrez A, Ferreira GM, Machuca J, Venthur H, Feres F, Hirata MH, Hirata RDC, Cerda A. Characterization of the adipogenic protein E4orf1 from adenovirus 36 through an in silico approach [Internet]. Journal of Molecular Modeling. 2020 ; 26 1-9 art. 285.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1007/s00894-020-04531-0
Trabalho de evento-resumo
Circulating miR-421 expression is associated with insulin resistance in metabolic syndrome patients (2019)
Bortolin, Raul Hernandes ; Braga, Aécio Assunção; Saldarriaga, Magda Elizabeth Graciano; Hirata, Thiago Dominguez Crespo ; Cerda, Alvaro; Freitas, Renata Caroline Costa de ; Wang, H. L; Borges, J. B; França, J. I. D; Masi, Laureane Nunes; Curi, Rui; Curi, Tania Cristina Pithon; Sampaio, M. F; Castro, L. R; Bastos, G. M; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Abstracts. Conference titles: American Association for Clinical Chemistry/AACC. Unidades: ICB, FCF
Subjects: SÍNDROME X METABÓLICA, RESISTÊNCIA À INSULINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORTOLIN, Raul Hernandes et al. Circulating miR-421 expression is associated with insulin resistance in metabolic syndrome patients. 2019, Anais.. Washington: AACC, 2019. . Acesso em: 06 jul. 2024.
APA
Bortolin, R. H., Braga, A. A., Saldarriaga, M. E. G., Hirata, T. D. C., Cerda, A., Freitas, R. C. C. de, et al. (2019). Circulating miR-421 expression is associated with insulin resistance in metabolic syndrome patients. In Abstracts. Washington: AACC.
NLM
Bortolin RH, Braga AA, Saldarriaga MEG, Hirata TDC, Cerda A, Freitas RCC de, Wang HL, Borges JB, França JID, Masi LN, Curi R, Curi TCP, Sampaio MF, Castro LR, Bastos GM, Hirata RDC, Hirata MH. Circulating miR-421 expression is associated with insulin resistance in metabolic syndrome patients. Abstracts. 2019 ;[citado 2024 jul. 06 ]
Vancouver
Bortolin RH, Braga AA, Saldarriaga MEG, Hirata TDC, Cerda A, Freitas RCC de, Wang HL, Borges JB, França JID, Masi LN, Curi R, Curi TCP, Sampaio MF, Castro LR, Bastos GM, Hirata RDC, Hirata MH. Circulating miR-421 expression is associated with insulin resistance in metabolic syndrome patients. Abstracts. 2019 ;[citado 2024 jul. 06 ]
Trabalho de evento-resumo
Caracterização da proteína adipogênica E4orf1 do adenovírus 36 através de técnicas de modelagem molecular (2019)
Ferreira, Glaucio Monteiro; Colina, Alvaro Oriel Gutierrez; Bortolin, Raul Hernandes; Freitas, Renata Caroline Costa de; Cerda, Alvaro; Hirata, Mario Hiroyuki
Source: Resumos. Conference titles: Congresso da Sociedade de Cardiologia do Estado de São Paulo. Unidade: FCF
Subjects: ADENOVÍRUS, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Glaucio Monteiro et al. Caracterização da proteína adipogênica E4orf1 do adenovírus 36 através de técnicas de modelagem molecular. 2019, Anais.. São Paulo: SOCESP, 2019. Disponível em: https://www.bp.org.br/crescer-juntos/socesp-2019-40-congresso-da-sociedade-de-cardiologia-do-estado-de-sao-paulo/. Acesso em: 06 jul. 2024.
APA
Ferreira, G. M., Colina, A. O. G., Bortolin, R. H., Freitas, R. C. C. de, Cerda, A., & Hirata, M. H. (2019). Caracterização da proteína adipogênica E4orf1 do adenovírus 36 através de técnicas de modelagem molecular. In Resumos. São Paulo: SOCESP. Recuperado de https://www.bp.org.br/crescer-juntos/socesp-2019-40-congresso-da-sociedade-de-cardiologia-do-estado-de-sao-paulo/
NLM
Ferreira GM, Colina AOG, Bortolin RH, Freitas RCC de, Cerda A, Hirata MH. Caracterização da proteína adipogênica E4orf1 do adenovírus 36 através de técnicas de modelagem molecular [Internet]. Resumos. 2019 ;[citado 2024 jul. 06 ] Available from: https://www.bp.org.br/crescer-juntos/socesp-2019-40-congresso-da-sociedade-de-cardiologia-do-estado-de-sao-paulo/
Vancouver
Ferreira GM, Colina AOG, Bortolin RH, Freitas RCC de, Cerda A, Hirata MH. Caracterização da proteína adipogênica E4orf1 do adenovírus 36 através de técnicas de modelagem molecular [Internet]. Resumos. 2019 ;[citado 2024 jul. 06 ] Available from: https://www.bp.org.br/crescer-juntos/socesp-2019-40-congresso-da-sociedade-de-cardiologia-do-estado-de-sao-paulo/
Trabalho de evento-resumo
Influence of polymorphisms LEP c.-2548A>G and LEPR c.668A>G on metabolic alterations in a pediatric population of Southern Chile (2019)
Hirata, Rosario Dominguez Crespo ; Brito, R; Manriquez, Victor; Aguilar-Farias, N; Chandía-Poblete, D; Navarro, J; Fajardo, Cristina Moreno ; Hirata, Mario Hiroyuki ; Cerda, Alvaro
Source: Abstracts. Conference titles: American Association for Clinical Chemistry/AACC. Unidade: FCF
Subjects: POLIMORFISMO, OBESIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Rosario Dominguez Crespo et al. Influence of polymorphisms LEP c.-2548A>G and LEPR c.668A>G on metabolic alterations in a pediatric population of Southern Chile. 2019, Anais.. Washington: AACC, 2019. . Acesso em: 06 jul. 2024.
APA
Hirata, R. D. C., Brito, R., Manriquez, V., Aguilar-Farias, N., Chandía-Poblete, D., Navarro, J., et al. (2019). Influence of polymorphisms LEP c.-2548A>G and LEPR c.668A>G on metabolic alterations in a pediatric population of Southern Chile. In Abstracts. Washington: AACC.
NLM
Hirata RDC, Brito R, Manriquez V, Aguilar-Farias N, Chandía-Poblete D, Navarro J, Fajardo CM, Hirata MH, Cerda A. Influence of polymorphisms LEP c.-2548A>G and LEPR c.668A>G on metabolic alterations in a pediatric population of Southern Chile. Abstracts. 2019 ;[citado 2024 jul. 06 ]
Vancouver
Hirata RDC, Brito R, Manriquez V, Aguilar-Farias N, Chandía-Poblete D, Navarro J, Fajardo CM, Hirata MH, Cerda A. Influence of polymorphisms LEP c.-2548A>G and LEPR c.668A>G on metabolic alterations in a pediatric population of Southern Chile. Abstracts. 2019 ;[citado 2024 jul. 06 ]
Trabalho de evento-resumo periodico
Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients (2019)
Bortolin, Raul Hernandes ; Freitas, Renata Caroline Costa de ; Genvigir, Fabiana Dalla Vecchia; Bonezi, Vivian; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Cerda, Alvaro; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Congress of São Paulo. Unidade: FCF
Subjects: EXPRESSÃO GÊNICA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORTOLIN, Raul Hernandes et al. Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf. Acesso em: 06 jul. 2024. , 2019
APA
Bortolin, R. H., Freitas, R. C. C. de, Genvigir, F. D. V., Bonezi, V., Felipe, C. R., Silva Junior, H. T., et al. (2019). Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
NLM
Bortolin RH, Freitas RCC de, Genvigir FDV, Bonezi V, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Hirata MH, Hirata RDC. Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 186 res. CFSP372.[citado 2024 jul. 06 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Vancouver
Bortolin RH, Freitas RCC de, Genvigir FDV, Bonezi V, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Hirata MH, Hirata RDC. Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 186 res. CFSP372.[citado 2024 jul. 06 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Trabalho de evento-resumo periodico
Characterization of the adipogenic protein E4orf1 of adenovirus 36 through molecular modeling techniques (2019)
Gutierrez, Alvaro; Ferreira, Glaucio Monteiro ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Cerda, Alvaro
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Congress of São Paulo. Unidade: FCF
Subjects: OBESIDADE, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUTIERREZ, Alvaro et al. Characterization of the adipogenic protein E4orf1 of adenovirus 36 through molecular modeling techniques. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf. Acesso em: 06 jul. 2024. , 2019
APA
Gutierrez, A., Ferreira, G. M., Hirata, M. H., Hirata, R. D. C., & Cerda, A. (2019). Characterization of the adipogenic protein E4orf1 of adenovirus 36 through molecular modeling techniques. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
NLM
Gutierrez A, Ferreira GM, Hirata MH, Hirata RDC, Cerda A. Characterization of the adipogenic protein E4orf1 of adenovirus 36 through molecular modeling techniques [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 29 res. CFSP057.[citado 2024 jul. 06 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Vancouver
Gutierrez A, Ferreira GM, Hirata MH, Hirata RDC, Cerda A. Characterization of the adipogenic protein E4orf1 of adenovirus 36 through molecular modeling techniques [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 29 res. CFSP057.[citado 2024 jul. 06 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Trabalho de evento-resumo
IRS2 rs1865434 variant is associated with adiposity and insulin resistance in brazilian subjects (2019)
Fajardo, Cristina Moreno ; Bortolin, Raul Hernandes ; Cerda, Alvaro; Freitas, Renata Caroline Costa de ; Oliveira, Raquel de; Moraes, Tamiris Invencioni; Malaquias, V. B; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Abstracts. Conference titles: American Association for Clinical Chemistry/AACC. Unidade: FCF
Subjects: ADIPOSIDADE, RESISTÊNCIA À INSULINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAJARDO, Cristina Moreno et al. IRS2 rs1865434 variant is associated with adiposity and insulin resistance in brazilian subjects. 2019, Anais.. Washington: AACC, 2019. . Acesso em: 06 jul. 2024.
APA
Fajardo, C. M., Bortolin, R. H., Cerda, A., Freitas, R. C. C. de, Oliveira, R. de, Moraes, T. I., et al. (2019). IRS2 rs1865434 variant is associated with adiposity and insulin resistance in brazilian subjects. In Abstracts. Washington: AACC.
NLM
Fajardo CM, Bortolin RH, Cerda A, Freitas RCC de, Oliveira R de, Moraes TI, Malaquias VB, Hirata MH, Hirata RDC. IRS2 rs1865434 variant is associated with adiposity and insulin resistance in brazilian subjects. Abstracts. 2019 ;[citado 2024 jul. 06 ]
Vancouver
Fajardo CM, Bortolin RH, Cerda A, Freitas RCC de, Oliveira R de, Moraes TI, Malaquias VB, Hirata MH, Hirata RDC. IRS2 rs1865434 variant is associated with adiposity and insulin resistance in brazilian subjects. Abstracts. 2019 ;[citado 2024 jul. 06 ]

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration